Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

Completed · Phase 3

Conditions studied: Pulmonary Hypertension

In brief

OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.

Key facts

Study ID

NCT00004497

Run by

United Therapeutics

Starts

1998-10-01

Expected to finish

2000-09-01

Last updated by the study team

2015-03-25

Who can join

Age: 8 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Los Angeles County Harbor-UCLA Medical Center — Torrance, California, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• University of Maryland Medical System — Baltimore, Maryland, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Columbia University College of Physicians and Surgeons — New York, New York, United States
• United Therapeutics Corporation — Research Triangle Park, North Carolina, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.